We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVB icon
701
Nuvation Bio
NUVB
$2.3B
-359,375
Closed -$3.06M
ON icon
702
CALL
ON Semiconductor
ON
$31.5B
-66,100
Closed -$435K
ORCL icon
703
PUT
Oracle
ORCL
$417B
-50,000
Closed -$122K
OXY icon
704
CALL
Occidental Petroleum
OXY
$59B
-160,000
Closed -$1.28M
PFE icon
705
Pfizer
PFE
$152B
-98,385
Closed -$5.81M
PFE icon
706
PUT
Pfizer
PFE
$152B
-106,300
Closed -$4K
PG icon
707
Procter & Gamble
PG
$336B
-9,227
Closed -$1.51M
PIII icon
708
P3 Health Partners
PIII
$41.9M
-1,500
Closed -$528K
PSQH.WS icon
709
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.3M
-101,974
Closed -$54K
PTGX icon
710
CALL
Protagonist Therapeutics
PTGX
$9.66B
-15,000
Closed -$88K
RCUS icon
711
CALL
Arcus Biosciences
RCUS
$3.67B
-31,700
Closed -$10K
REE
712
DELISTED
REE Automotive
REE
-15,753
Closed -$2.62M
SAND
713
CALL
DELISTED
Sandstorm Gold
SAND
-28,300
Closed -$1K
FLNA
714
CALL
Filana Therapeutics
FLNA
$47.4M
-7,000
Closed -$26K
FLNA
715
Filana Therapeutics
FLNA
$47.4M
-12,700
Closed -$555K
FLNA
716
PUT
Filana Therapeutics
FLNA
$47.4M
-32,700
Closed -$161K
SEER icon
717
Seer Inc
SEER
$119M
-7,596
Closed -$173K
SEER icon
718
PUT
Seer Inc
SEER
$119M
-12,500
Closed -$49K
SIRI icon
719
CALL
SiriusXM
SIRI
$9.63B
-5,000
Closed -$9K
SNDX icon
720
Syndax Pharmaceuticals
SNDX
$1.81B
-377
Closed -$8K
SNDX icon
721
PUT
Syndax Pharmaceuticals
SNDX
$1.81B
-10,000
Closed -$1K
SOND
722
DELISTED
Sonder
SOND
-1,524
Closed -$304K
SPGI icon
723
S&P Global
SPGI
$121B
-128
Closed -$60K
SPGI icon
724
PUT
S&P Global
SPGI
$121B
-11,600
Closed -$3K
SPWR icon
725
SunPower Inc
SPWR
$49.8M
-127,691
Closed -$1.24M

Similar funds

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.